Is Open Access Finally on
the Ascendancy?
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O pen-access publishing has always been a field in which the words are prone to race ahead of the facts. For more than a decade, advocates and some funding agencies have been proselytizing for open access, frequently pledging that all of their work is going to be rendered open to all.
In 2012, we heard that the Research Councils UK (RCUK) would pursue a new, comprehensive, open-access policy. On 17 July, the European Union At this rate, it is only a matter of time before the United Nations declares an open-access policy for research published from outer space.
And yet, the beast remains untamed. Just try sitting at your home computer, shorn of your university's online journal subscriptions, and attempt to access the literature on a problem of interest, and see how far you get. 
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Blackburn, Jack Szostak, Oliver Smithies, and Barry Marshall. "The success of PLOS ONE was a real game changer," says Robert Kiley, head of digital services at the Wellcome Trust, the largest research philanthropy in the world, which has relentlessly championed open-access publishing for the work that it funds. That said, the long struggle between the open-access movement and traditional publishers-both commercial and nonprofit-has been characterized more by steady attrition than by game-changing breakthroughs. From Harnad's battle cry to numerous mandates and calls for boycotts of traditional publishers, such as last year's Cost of Knowledge petition, led by University of Cambridge mathematician Tim Gowers and targeted at Elsevier, many scientists have been missing from the barricades.
For those seeking tenured positions or looking out for their students' futures, the top priority remains publication in a reputable traditional journal with a high impact factor. Open access is most popular with "those who are young and don't care and those who have already got tenure," notes Jan Velterop, a UK publisher and original signatory to the Budapest open-access journals accounted for just 2.5 percent of the total literature and predicted they would remain "a drop in the ocean." Analysts at Exane BNP Paribas, commenting on how Elsevier, the world's largest scientific publisher and the open-access movement's bête noir, would be affected by the European Union's new policy in July, said that it would have "no impact" until 2022-and recommended purchasing the stock.
Perhaps the analysts are being a little too sanguine, but it has been 19 years since Stevan Harnad, a cognitive scientist at the University of Southampton, first upset the applecart with his online "subversive proposal"-that all researchers should henceforth selfarchive their research anonymously, for free (see http://eprints.soton.ac.uk/ 253351) Advocates of open access believe that the 2006 launch and subsequent explosive growth of PLOS ONE, a journal that publishes peer-reviewed papersregardless of their importance or originality-has lent great momentum to their efforts. In 2010, PLOS ONE published 6749 papers, making it the largest scientific journal in the world. In 2012, it was set to publish some 20,000 papers, including several that have been often cited and were of very high quality. For example, a study by William Chan of the Fred Hutchinson Cancer Research Center in Seattle, in which male DNA from a fetus was shown to be able to find its way into a mother's brain through a process called microchimerism, was published in PLOS ONE in September, drawing widespread international attention. PLOS ONE has also published papers by five Nobel Prize-winning biologists: Francoise Barre-Sinoussi, Elizabeth "If you believe that high-quality publishing is an important part of the research process, it has to be paid for in some way," says Jubb. "The UK has a very good record of publishing in high-quality journals. That has a cost; it can't be done for free." publish their work on their own university repositories, "puts the interests of publishers ahead of the interests of research."
The European Union's new openaccess policy for its next major research program, Horizon 2020, which will cost about €80 billion and will run from 2014 to 2020, is still to be formulated in detail, but its July announcement makes clear that it will back green as Feature by the open-access movement. Vitek Tracz, the London-based publisher whose BioMed Central biology journals were the first to prove that openaccess models could make money, before he sold them to Springer in 2009, has started an online publishing service called F1000 Research, which will test some of these approaches. Papers submitted to F1000 Research will be published almost instantaneously, after staff editors have performed an initial review. Referees nominated by the author from a list of 2000 volunteers will then mark them as "yes" or "no" or "yes, with reservations." The paper will be considered "published" once it attracts two ticks. F1000 Research is a "publishing and refereeing machine," says Tracz. "It will be faster, and it will all be in the open." Authors pay $1000 for papers, and $500 for short items.
David Lipman, director of the National Center for Biotechnology Information at the NIH and one of the prime movers of the open-access movement, says that F1000 Research "is implementing a number of very innovative approaches and could really change biomedical publishing." John Tagler, vice president of the Association of American Publishers, says that publishers told the White House that they object to a one-sizefits-all approach to the open-access question. He says that the group would accept something akin to the UK plan. "That's what the Finch report says: Don't throw out the baby with the bathwater," he says. Data can be opened up, but "we don't want to sink the whole system in the process."
It seems, however, that some funders are preparing to turn the screws on the existing system. In June, the Londonbased Wellcome Trust severely tightened its own open-access policy, telling grantees, for example, that their final grant payment would not be made until their material is up on UK PubMed Central-and that their new grant applications would not go out to peer review until the work done under their old grants is placed there.
Most radically, as of April 2013, Wellcome will expect all of its work to be published under a generous Creative Commons license that allows reuse, even for commercial purposes. "We want our data to be anywhere and everywhere," says Wellcome's Kiley.
The journal eLife represents another attempt to spur open access, by launching a top-quality online life-sciences journal that will compete for papers with the likes of Nature and Science, publishing its papers immediately, with open access, and at no charge to authors. eLife will use a novel refereeing process that cuts out nonessential feedback to authors. "We've had a lot of feedback about the length-and painfulness-of journals' reviewing processes," says Patterson. "We think that eLife can provide a swift and efficient process."
The journal is just one of a stream of new publishing approaches spawned to no rules at all in some smaller and poorer member states.
In the United States, the federal government's approach to open access has edged steadily along since 2005, when the NIH first asked its grantees to deposit their papers on the PubMed Central repository within 12 months of their publication. The request became a mandate in 2008, and today, according to agency officials, about 75 percent of NIH grantees comply with it. However, the 12-month compliance period is viewed by open-access advocates as being far too long. Furthermore, the US National Science Foundation (NSF) and most other federal agencies have never replicated the NIH mandate. The America COMPETES Act of 2007 asked the NSF to tell all its investigators to complete a short project-outcomes report at the end of each grant, summarizing what had been achieved in everyday language and citing the resultant publications, but in the absence of any other legislative instruction or an executive order from the White House, the NSF does not ask its grantees to do anything else to make their findings available to the public.
Heather Joseph, executive director of the Scholarly Publishing and Academic Resources Coalition (SPARC)-an open-access lobby group set up by university libraries-says that she has grown used to the long, hard grind of pushing for change on the issue. "You have to be pragmatic, working on policy in Washington, DC," she reflects. "We've seen a typically slow, iterative process over the years, and it has slowed down now; the stakes are a lot higher."
In 2012, open-access advocates and publishers again fought themselves to an impasse in the halls of Congress. An Elsevier-backed bill to rescind the current NIH policy was introduced by two members of Congress-Darryl Issa (R-CA) and Carolyn Maloney (D-NY)-in February but then withdrawn. A rival bill to deepen the policy and extend it across the federal government was sponsored by Senator John Cornyn (R-TX), with bipartisan "Clearly, there is a split, and I think that's very unfortunate," says Jubb. In an e-mail sent in October to his BOAI cosignatories, Steven Harnad said that "friendly" publishers, including Tracz, had "made profitable and influential use of the ideology of open-access for publishing opportunities, but, when push comes to shove, their loyalty is and always was to the publishing business, not to open access."
Harnad argues that with 150 institutional mandates and more than 3000 institutional repositories now in place 
